Coloplast Raises Guidance For Full-Year Growth

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

The half-year results are affected by the provision of DKK 1bn to cover potential settlements and other costs in connection with litigation in the US that was announced on May 2 2014. The provision is recorded as special items.

EBIT before special items was up by 14% to DKK 1,997 million, with an EBIT margin before special items of 33% compared with 31% in the first quarter of last year.

Help employers find you! Check out all the jobs and post your resume.
MORE ON THIS TOPIC